Skip to main content
← All data ties

Physical, Engineering, And Life Sciences R&D (Except Biotechnology) in FY2024 (NAICS 541712)

Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) (NAICS 541712) and fiscal year 2024 meet at $132,403,855,766.33 in USAspending.gov yearlyTrend obligations. About 90.9% of the industry extract ($145,644,197,179.80) sits in FY2024 on this snapshot. That pair is Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) and FY2024 — not a lab roster, not a biotechnology mix-in, and not an outlay register. 8,022 is the industry-wide award count in this extract, not a FY2024 action census. Correlation is not causation.

Key figures

  • Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) in FY2024: $132,403,855,766.33 (NAICS 541712).
  • About 90.9% of the industry’s $145,644,197,179.80 extract total.
  • 8,022 is the industry-wide award count, not a FY2024 row total.
  • The join is NAICS 541712 × FY2024, not a lab roster.
  • Figures are USAspending obligations, not outlays.

NAICS 541712 × FY2024 is an except-biotech R&D join

This page is a join: Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) and fiscal year 2024. $132,403,855,766.33 is the obligation sum USAspending.gov attributes to NAICS 541712 in that fiscal year on the yearlyTrend series. It is not every federal dollar in FY2024, not Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology)’s lifetime book restated as a single year, and not an outlay register. NAICS 541712 is the industry parent. FY2024 federal spending is the year parent. Correlation is not causation.

The industry extract totals $145,644,197,179.80. FY2024’s $132,403,855,766.33 is the year slice of that book, about 90.9%. Remaining industry dollars sit in other fiscal years on the same NAICS, not inside this join. 8,022 is the industry-wide award count in this extract, not a FY2024 action count. Do not divide $132,403,855,766.33 by 8,022 and call the result a typical FY2024 award. Unique recipients are unpublished. This page will not invent contractors. FEC contribution tables do not fund these USAspending obligations. This page will not invent laboratories, principal investigators, or contractors.

Do not mix 541712 with 541710 or 541715

USAspending labels industry 541712 as Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology). That code produced $132,403,855,766.33 when filtered to FY2024. The industry hub does not require a FY2024 filter. The fiscal-year hub does not require NAICS 541712. Only this tie applies both filters. The packet does not split physical from engineering from life sciences. The except-biotechnology clause is part of the NAICS label; this page does not add 541711 dollars.

SpendingVault does not grade Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) on output, headcount, or policy. $132,403,855,766.33 is an obligation sum, not a verdict. NAICS 541710 and 541715 are different R&D keys. Mixing those books into this cell would leave the join. Open NAICS 541712 for the industry rollup without the year filter, FY2024 federal spending for the year rollup without the industry filter, All industries for the NAICS index, and All spending ties for other pairs.

FY2024 on the yearlyTrend series

Fiscal year 2024 on this join is a USAspending yearlyTrend bucket, not a claim that every obligated dollar was performed in calendar 2024. Awards can list FY2024 while performance stretches across adjacent years. FY figures can be incomplete for a current year; this snapshot reports $132,403,855,766.33 as given. Other fiscal years for NAICS 541712 belong on those ties.

FY2024 federal spending shows how Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) sits beside other industries in the same year extract. $132,403,855,766.33 is one industry-year column, not the year table. Quoting it as all of FY2024 would drop every other NAICS. The 90.9% industry share describes this join, not a ranking of industries as winners or losers. The except-biotechnology clause is a coding boundary, not a scientific ranking.

8,022 is the industry parent count

8,022 awards describe the Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) extract, not the FY2024 slice alone. Mixing that count with $132,403,855,766.33 invents a per-award FY figure the packet does not publish. Treat 8,022 as the industry parent’s action count. Modifications can add rows on the parent. This cell is not a lab roster, not a biotechnology mix-in, and not a named-prime file.

Obligations versus research already performed

An obligation is a recorded commitment. An outlay is a payment from the Treasury. $132,403,855,766.33 is the commitment figure for Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) in FY2024. This packet has no outlay total, so none is invented. Citing the figure as cash already spent over-reads the field. Keep both sides in the citation: Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) (NAICS 541712) and FY2024.

Agency R&D budget justifications answer other questions. They are not the source of this cell. If a chart mixes commercial activity with NAICS 541712 in FY2024, the chart has left the federal award series.

How to cite the 541712 × FY2024 pair

Cite: Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) (NAICS 541712) obligated $132,403,855,766.33 in FY2024, per USAspending.gov yearlyTrend. Keep both keys. Keep the word obligations. Prefer NAICS 541712 and FY2024 federal spending when live tables move. None of those links convert this cell into a lab roster, into a FY2024 award census this packet omits, or into a contractor list. Later bulk files can move both the FY2024 dollars and the industry $145,644,197,179.80 parent; quote the live hubs when the overlay and this snapshot diverge. All spending ties lists other industry-by-year pairs on the same obligation metric.

Questions

How much R&D except biotechnology spending is in FY2024?
USAspending.gov records $132,403,855,766.33 in NAICS 541712 obligations for fiscal year 2024. That is an industry × year join, not an outlay and not all of FY2024 federal spending. The slice is about 90.9% of the industry’s $145,644,197,179.80 extract total.
Does 8,022 awards mean 8,022 labs in FY2024?
No. 8,022 is the industry-wide award-action count in this extract, not a FY2024-only row total and not a lab count. Unique recipients are unpublished. Do not divide $132,403,855,766.33 by that count.
Is $132,403,855,766.33 cash already paid?
No. Obligations are commitments recorded on USAspending.gov awards. Outlays are a different concept and are not this packet’s headline. FY figures can be incomplete. Prefer the live industry and year hubs if the tables moved.
Where are the live NAICS 541712 and FY2024 tables?
NAICS 541712 is the industry parent. FY2024 federal spending is the year parent. All industries is the NAICS index. All spending ties lists other pairs. This page quotes 541712 × FY2024 at $132,403,855,766.33.

USAspending.gov NAICS yearlyTrend by fiscal year. Obligations are not outlays. FY figures can be incomplete for the current year.